Newstral
Article
The Hindu on 2020-11-18 14:25
Pfizer ends COVID-19 vaccine trial with 95% efficacy, to seek emergency-use authorisation
Related news
- Pfizer ends COVID-19 vaccine trial with 95% efficacy, to seek emergency-use authorisationThe Hindu
- EPfizer ends Covid-19 trial with 95% efficacy, to seek emergency-use authorizationekathimerini.com
- HPfizer Ends COVID-19 Trial With 95% Efficacyhamodia.com
- Pfizer ends COVID-19 vaccine trial with 95 per cent efficacySydney Morning Herald
- Pfizer reports final vaccine results: 95% efficacyArs Technica
- Pfizer Ends COVID-19 Trial, Seeks U.S. Emergency-use AuthorizationHaaretz
- 'It's just overwhelming': Moderna to seek emergency authorisation of vaccineSydney Morning Herald
- Pfizer seeks emergency use authorisation for its COVID-19 vaccine in IndiaThe Hindu
- FDA Authorizes ‘Mix-And-Match’ COVID-19 Boosters, Pfizer Touts 95% Efficacyjacksonfreepress.com
- EUK authorizes Pfizer coronavirus vaccine for emergency useekathimerini.com
- Pfizer, BioNTech plan filing as vaccine proves 95% effectivethestar.com
- U.K. authorizes Pfizer coronavirus vaccine for emergency usestaradvertiser.com
- BioNTech, Pfizer ask Europe to OK vaccine for emergency useseattletimes.com
- Pfizer to seek emergency approval for COVID vaccine next monthtimesofisrael.com
- Britain authorizes Pfizer coronavirus vaccine for emergency useAlaska Dispatch News
- Pfizer to seek FDA okay within days as trial results show vaccine 95% effectivetimesofisrael.com
- HPfizer Seeking Emergency Use of Its COVID-19 Vaccine in U.S.hamodia.com
- BPfizer announces 89% efficacy in final analysis of COVID-19 pillbusinessday.ng